41 results
Page 2 of 3
8-K
1u6bn2viwsh
27 Oct 20
Sobi obtains global co-development and exclusive ex-U.S. commercialization rights for systemic pegcetacoplan, a targeted C3 therapy
7:17am
8-K
m663093fl40cx3
6 Apr 20
Departure of Directors or Certain Officers
8:30am
424B5
puqy v7ba
9 Jan 20
Prospectus supplement for primary offering
5:25pm
424B5
21js1t 9l
7 Jan 20
Prospectus supplement for primary offering
4:19pm
424B5
wc9nih lyvs9h8
7 Mar 19
Prospectus supplement for primary offering
4:28pm
424B5
bhyohzeq
6 Mar 19
Prospectus supplement for primary offering
4:07pm
10-K
i5an96gwt1tg882
19 Mar 18
Annual report
12:00am
10-Q
hhmj 69c6w4
20 Dec 17
Quarterly report
12:00am